首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   59660篇
  免费   6194篇
  国内免费   4251篇
耳鼻咽喉   670篇
儿科学   655篇
妇产科学   385篇
基础医学   5793篇
口腔科学   915篇
临床医学   7859篇
内科学   7738篇
皮肤病学   805篇
神经病学   2777篇
特种医学   2267篇
外国民族医学   19篇
外科学   5561篇
综合类   12540篇
现状与发展   23篇
一般理论   1篇
预防医学   4885篇
眼科学   1513篇
药学   6797篇
  92篇
中国医学   4366篇
肿瘤学   4444篇
  2024年   247篇
  2023年   999篇
  2022年   2805篇
  2021年   3644篇
  2020年   2783篇
  2019年   2115篇
  2018年   2377篇
  2017年   2247篇
  2016年   1968篇
  2015年   3113篇
  2014年   3856篇
  2013年   3746篇
  2012年   5186篇
  2011年   5414篇
  2010年   3872篇
  2009年   3217篇
  2008年   3409篇
  2007年   3173篇
  2006年   2923篇
  2005年   2373篇
  2004年   1806篇
  2003年   1876篇
  2002年   1387篇
  2001年   1141篇
  2000年   882篇
  1999年   762篇
  1998年   402篇
  1997年   443篇
  1996年   341篇
  1995年   293篇
  1994年   238篇
  1993年   129篇
  1992年   167篇
  1991年   153篇
  1990年   115篇
  1989年   104篇
  1988年   100篇
  1987年   88篇
  1986年   75篇
  1985年   54篇
  1984年   38篇
  1983年   16篇
  1982年   7篇
  1981年   9篇
  1980年   4篇
  1979年   6篇
  1978年   1篇
  1975年   1篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
目的研究晚期肺癌化疗患者发生医院感染的病原学特点,分析其危险因素,降低晚期肺癌化疗患者医院感染率。方法选择2012年1月-2015年12月收治的532例晚期肺癌化疗患者为研究对象,采集患者痰液或呼吸道分泌物标本进行细菌培养,应用SAS 9.3软件进行统计分析,并分析晚期肺癌化疗患者发生医院感染的危险因素。结果 125例晚期肺癌化疗患者发生医院感染,感染率为23.50%,其主要感染部位为呼吸道、胃肠道、口腔黏膜,分别占52.00%、15.20%、14.40%;共分离病原菌104株,其中革兰阴性菌51株占49.04%、革兰阳性菌30株占28.85%、真菌23株占22.11%;logistics回归显示,住院时间长、接受侵入性操作、使用抗菌药物是晚期肺癌化疗患者发生医院感染的危险因素。结论晚期肺癌化疗患者医院感染率较高,主要病原菌以革兰阴性菌为主,通过缩短患者住院时间、减少侵入性操作、合理使用抗菌药物等措施,降低晚期肺癌化疗患者医院感染的发生。  相似文献   
5.
6.
7.
Objective To observe the clinical characteristics and prognosis of patients with rapidly progressive glomerulonephritis (RPGN) caused by lupus nephritis, antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis, or primary glomerulonephritis who were treated with peritoneal dialysis (PD) and then withdrew PD because of renal recovery. Methods Data of the above patients were retrospectively analyzed. The patients were diagnosed as RPGN and received PD therapy in Kidney Disease Center, the First Affiliated Hospital, College of Medicine, Zhejiang University from February 2009 to August 2018. The patients were divided into early withdrawal group (PD time≤183 days, n=24) and late withdrawal group (PD time>183 day, n=24). The differences of clinical characteristics between the two groups were compared. The cumulative incidence of adverse events in both groups was analyzed using Kaplan-Meier curves. Cox proportional hazards model was used to analyze the risk factors influencing the prognosis of patients. Results Forty-eight RPGN patients were included. The median time of maintaining PD was 178(76, 378) days. Compared with the late withdrawal group, the patients in early withdrawal group had lower levels of urine volume, serum albumin and parathyroid hormone, and lower rates of gross hematuria and hypertension at the beginning of PD, and received higher rates of methylprednisolone impulse, combined immunosuppressive agents, and hemodialysis or continuous renal replacement therapy (all P<0.05). At the time of PD withdrawal, the levels of serum creatinine, serum calcium, serum albumin and parathyroid hormone in the early withdrawal group were significantly lower than those in the late withdrawal group (all P<0.05). The Kaplan-Meier curves showed that there was no significant difference in the cumulative survival of patients in both groups (log-rank test χ2=3.485, P=0.062). Cox regression analysis revealed serum creatinine≥209 μmol/L at the time of PD withdrawal was an independent risk factor for poor prognosis (HR=5.253,95%CI 1.757-15.702, P=0.003). Conclusions PD can be used for RPGN patients caused by lupus nephritis, ANCA-associated vasculitis and primary nephritis. Serum creatinine≥209 μmol/L at the time of PD withdrawal is an independent risk factor for poor prognosis.  相似文献   
8.
9.
Limb shortening is a problem associated with surgery for osteosarcoma of the lower extremity in adolescents, as the tumors frequently occur near the epiphysis. Herein we report the use of a less invasive stabilization system (LISS) and an intermittent fixation method to preserve the growth function of epiphysis in an 11-year-old patient with an osteosarcoma of the distal femur.The 11-year-old male presented with left knee enlargement and pain for 2 weeks, and magnetic resonance imaging (MRI) and biopsy were consistent with osteosarcoma of the left distal femur. After preoperative chemotherapy, en bloc tumor resection was performed with margins based on MRI findings preserving the epiphyseal growth plate, the tumor cavity was filled with inactivated bone and bone cement, and a LISS was used to stabilize the femur. Aggressive postoperative chemotherapy was given. Approximately 105 weeks after surgery radiography showed that the distal end of the plate had moved superior to the epiphysis along with bone growth. Locking screws were placed in the distal part of the LISS plate to stabilize the re-implanted bone, and external fixation was not needed.The patient was able to walk with the crutches 1 week postoperatively, and bear weight on the extremity 6 weeks postoperatively. At 6 years after surgery, the patient''s height had increased 52 cm, shortening of the affected limb was only 1 cm, and the circumference of the affected limb was 2 cm smaller than that of the contralateral limb. There was no significant discomfort in the affected limb, and there was no gait abnormality. The patient could jump and run, and could participate in sports including basketball and badminton to the same degree as his peers.In summary, the novel method of bone reconstruction and fixation provided good results in a child with an osteosarcoma of the distal femur. This fixation method preserves the osteogenic function of the epiphysis and restored bone integrity simultaneously, and provides good functional recovery.  相似文献   
10.
目的 克隆土耳其斯坦东毕吸虫磷酸丙糖异构酶的全长基因。方法 根据日本血吸虫和曼氏血吸虫磷酸丙糖异构酶基因的保守区设计引物,利用RT—PCR扩增出土耳其斯坦东毕吸虫磷酸丙糖异构酶基闪的大片段,再结合RACE技术分别得到磷酸丙糖异构酶基因的3’端和5’端,将3部分序列拼接后获得磷酸丙糖异构酶基因全长cDNA序列,并提交GenBank。结果 成功克隆了土耳其斯坦东毕吸虫磷酸丙糖异构酶基因全长cDNA序列并提交GenBank,登录号为DQ092331。结论 土耳其斯坦东毕吸虫磷酸丙糖异构酶基因全长cDNA的克隆为进一步表达及其生物学性能的分析提供了理论基础。  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号